MedNexus
2021年 · 第134卷第10期
出版日期 2021-05-20电子版 ￥0.00元
MedNexus
- 全部
- Editorial
- Original Article
- Clinical Observation
- Technical Notes
- Rapid Report
- Correspondence
Editorial
开放获取
非小细胞肺癌的免疫治疗：进展与挑战Fei Zhou, Cai-Cun Zhou
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001338
摘要
在过去10年中，靶向程序性死亡-1（PD-1）/程序性死亡配体1（PD-L1）轴的免疫检查点抑制剂（ICIs）改变了非小细胞肺癌（NSCLC）的治疗前景，并在一部分患者中产生了长期生存益处。在这篇社论中，我们重点关注了ICIs在非小细胞肺癌患者中的最新进展和挑战。
Original Article
开放获取
中国汉族女性全基因组长非编码RNA关联研究确定lncHSAT164为乳腺癌新易感基因Jing-Kai Xu, Guo-Zheng Li, Zhi Li, Wen-Jing Li, Run-Sheng Chen, Bo Zhang, Xue-Jun Zhang
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001429
摘要
Background:
Single-nucleotide polymorphisms (SNPs)-associated genes and long non-coding RNAs (lncRNAs) can contribute to human disease. To comprehensively investigate the contribution of lncRNAs to breast cancer, we performed the first genome-wide lncRNA association study on Han Chinese women.
Methods:
We designed an lncRNA array containing >800,000 SNPs, which was incorporated into a 96-array plate by Affymetrix (CapitalBio Technology, China). Subsequently, we performed a two-stage genome-wide lncRNA association study on Han Chinese women covering 11,942 individuals (5634 breast cancer patients and 6308 healthy controls). Additionally, in vitro gain or loss of function strategies were performed to clarify the function of a novel SNP-associated gene.
Results:
We identified a novel breast cancer-associated susceptibility SNP, rs11066150 (Pmeta = 2.34 × 10-8), and a previously reported SNP, rs9397435 (Pmeta= 4.32 × 10-38), in Han Chinese women. rs11066150 is located in NONHSAT164009.1 (lncHSAT164), which is highly expressed in breast cancer tissues and cell lines. lncHSAT164 overexpression promoted colony formation, whereas lncHSAT164 knockdown promoted cell apoptosis and reduced colony formation by regulating the cell cycle.
Conclusions:
Based on our lncRNA array, we identified a novel breast cancer-associated lncRNA and found that lncHSAT164 may contribute to breast cancer by regulating the cell cycle. These findings suggest a potential therapeutic target in breast cancer.
开放获取
糖尿病对缺血性心力衰竭患者手术血运重建长期预后的影响：一项倾向评分匹配研究Meng Liu, Hua-Jun Zhang, Han Song, Nan Cheng, Yuan-Bin Wu, Rong Wang
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001421
摘要
Background:
Diabetes mellitus (DM) is an important risk factor in the long-term outcomes of surgical revascularization. However, few studies have focused on patients with ischemic heart failure (IHF) and DM, and the results are controversial. This study aimed to evaluate the effect of DM on the long-term outcomes of IHF patients undergoing coronary artery bypass grafting (CABG).
Methods:
In this propensity-matched study, data of IHF patients who underwent CABG in our hospital from January 2007 to December 2017 were analyzed. With a mean 73-month follow-up time, the patients were divided into two groups according to whether they had DM. The primary endpoint was all-cause death, and the secondary endpoint was a composite of all-cause death, stroke, recurrent myocardial infarction, and revascularization.
Results:
There was no significant difference in all-cause mortality between the two groups (5.8% vs. 4.1%, P = 0.216). The incidence of main adverse cardiovascular and cerebrovascular events (MACCE) in the secondary endpoint was significantly higher in the DM group than that in the non-DM group (10.4% vs. 8.1%, P = 0.023).
Conclusions:
DM can negatively affect the long-term outcomes of IHF patients undergoing CABG by significantly increasing the overall incidence of MACCE, though the long-term survival does not show a significant difference between the DM and non-DM patients.
开放获取
人绒毛膜促性腺激素联合人更年期促性腺激素和促性腺激素释放激素泵治疗男性青少年先天性低促性腺激素性性腺功能减退症的疗效和安全性Ying Liu, Xiao-Ya Ren, Ya-Guang Peng, Shao-Ke Chen, Xin-Ran Cheng, Miao Qin, Xiao-Ling Wang, Yan-Ning Song, Li-Jun Fan, Chun-Xiu Gong
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001419
摘要
Background:
Compared to adult studies, studies which involve the treatment of pediatric congenital hypogonadotropic hypogonadism (CHH) are limited and no universal treatment regimen is available. The aim of this study was to evaluate the feasibility of human chorionic gonadotropin (hCG)/human menopausal gonadotropin (hMG) therapy for treating male adolescents with CHH.
Methods:
Male adolescent CHH patients were treated with hCG/hMG (n = 20) or a gonadotropin-releasing hormone (GnRH) pump (n = 21). The treatment was divided into a study phase (0-3 months) and a follow-up phase (3-12 months). The testicular volume (TV), penile length (PL), penis diameter (PD), and sex hormone levels were compared between the two groups. The TV and other indicators between the groups were analyzed using a t-test (equal variance) or a rank sum test (unequal variance).
Results:
Before treatment, there was no statistical difference between the two groups in terms of the biochemistry, hormones, and other demographic indicators. After 3 months of treatment, the TV of the hCG/hMG and GnRH groups increased to 5.1 ± 2.3 mL and 4.1 ± 1.8 mL, respectively; however, the difference was not statistically significant (P > 0.05, t= 1.394). The PL reached 6.9 ± 1.8 cm and 5.1 ± 1 .6 cm (P < 0.05, t= 3.083), the PD reached 2.4 ± 0.5 cm and 2.0 ± 0.6 cm (P < 0.05, t= 2.224), respectively, in the two groups. At the end of 6 months of treatment, biomarkers were in normal range in the two groups. Compared with the GnRH group, the testosterone (T) level and growth of PL and PD were significantly greater in the hCG/hMG group (all P < 0.05). While the TV of both groups increased, the difference was not statistically significant (P > 0.05, t = 0.314). After 9 to 12 months of treatment, the T level was higher in the hCG/hMG group. Other parameters did not exhibit a statistical difference.
Conclusions:
The hCG/hMG regimen is feasible and effective for treating male adolescents with CHH. The initial 3 months of treatment may be a window to optimally observe the strongest effects of therapy. Furthermore, results from the extended time-period showed positive outcomes at the 1-year mark; however, the long-term effectiveness, strengths, and weaknesses of the hCG/hMG regimen require further research.
Trial Registration:
ClinicalTrials.gov, NCT02880280; https://clinicaltrials.gov/ct2/show/NCT02880280.
开放获取
乙型肝炎核心相关抗原反映慢性乙型肝炎患者的病毒复制和蛋白质产生Jun Li, Zhao Wu, Gui-Qiang Wang, Hong Zhao, China HepB-Related Fibrosis Assessment Research Group
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001418
摘要
Background:
Hepatitis B core-related antigen (HBcrAg) is a promising disease-monitoring marker for chronic hepatitis B (CHB). We investigated correlations between HBcrAg with antiviral efficacy and virological and histological variables.
Methods:
One hundred and forty-five CHB patients from the mainland of China between August 2013 and September 2016 who underwent liver biopsy received entecavir therapy and had paired liver biopsy at 78 weeks. We analyzed correlations between HBcrAg and virological and histological variables in hepatitis B e antigen (HBeAg)-positive and HBeAg-negative patients. We also explored the predictors of HBeAg loss after 78 weeks of antiviral therapy. Pearson correlation analysis and logistic forward stepwise regression were the main statistic methods.
Results:
HBeAg-positive patients (n = 93) had higher baseline HBcrAg (median 7.4 vs. 5.3 log10 U/mL P < 0.001) and greater HBcrAg declines (median 1.6 vs. 0.9 log10 U/mL P= 0.007) than HBeAg-negative patients after 78 weeks of therapy. At baseline, HBcrAg correlated with hepatitis B virus (HBV) DNA in both HBeAg-positive (r = 0.641, P < 0.001) and -negative patients (r = 0.616, P < 0.001), with hepatitis B surface antigen (HBsAg) in HBeAg-positive patients (r = 0.495, P < 0.001), but not with anti-hepatitis B virus core antibody (anti-HBc). Weak correlations existed between HBcrAg, histology activity index (HAI; r = 0.232, P= 0.025), and Ishak fibrosis score (r= -0.292, P= 0.005) in HBeAg-positive patients. At 78 weeks, significant correlations existed only between HBcrAg and anti-HBc in HBeAg-positive (r = -0.263, P = 0.014) and HBeAg-negative patients (r= -0.291, P= 0.045). Decreased HBcrAg significantly correlated with reduced HBV DNA (r= 0.366, P= 0.001; r= 0.626, P < 0.001) and HBsAg (r = 0.526, P = 0.001; r = 0.289, P = 0.044) in HBeAg-positive and -negative patients, respectively, and with reduced HAI in HBeAg-positive patients (r = 0.329, P = 0.001). Patients with HBeAg loss (n = 29) showed a larger reduction in HBcrAg than those without (median 2.3 vs. 1.3 log10 U/mL, P = 0.001). In multivariate analysis, decreased HBcrAg was an independent predictor of HBeAg loss (P = 0.005).
Conclusions:
HBcrAg reflects viral replication and protein production. Decreased HBcrAg could predict HBeAg loss after antiviral therapy.
Trial registration:
Clinical Trials.gov: NCT01962155; https://www.clinicaltrials.gov/ct2/show/NCT01962155?term=NCT01962155&draw=2&rank=1
开放获取
卵泡抑素相关蛋白1与抗中性粒细胞胞浆抗体相关性血管炎患者功能状态的关系Taejun Yoon, Sung Soo Ahn, Jung Yoon Pyo, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001454
摘要
Background:
Follistatin-like 1 (FSTL1) plays both pro-inflammatory and anti-inflammatory roles in the inflammatory processes. We investigated whether serum FSTL1 could predict the current anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)-specific indices.
Methods:
We randomly selected 74 patients with AAV from a prospective and observational cohort of Korean patients with AAV. Clinical and laboratory data and AAV-specific indices were recorded. FSTL1 concentration was determined using the stored sera. The lowest tertile of the short-form 36-item health survey (SF-36) was defined as the current low SF-36. The cutoffs of serum FSTL1 for the current low SF-36 physical component summary (PCS) and SF-36 mental component summary (MCS) were extrapolated by the receiver operator characteristic curve.
Results:
The median age was 62.5 years (55.4% were women). Serum FSTL1 was significantly correlated with SF-36 PCS (r = -0.374), SF-36 MCS (r = -0.377), and C-reactive protein (CRP) (r = 0.307), but not with Birmingham vasculitis activity score (BVAS). In the multivariable linear regression analyses, BVAS, CRP, and serum FSTL1 were independently associated with the current SF-36 PCS (β = -0.255, β = -0.430, and β = -0.266, respectively) and the current SF-36 MCS (β = -0.234, β=-0.229, and β= -0.296, respectively). Patients with serum FSTL1 ≥779.8 pg/mL and those with serum FSTL1 ≥841.6 pg/mL exhibited a significantly higher risk of having the current low SF-36 PCS and SF-36 MCS than those without (relative risk 7.583 and 6.200, respectively).
Conclusion:
Serum FSTL1 could predict the current functional status in AAV patients.
开放获取
1990年至2017年中国人类免疫缺陷病毒/获得性免疫缺陷综合征患病率、发病率和死亡率：2017年全球疾病负担研究数据的二次分析Xue-Jiao Liu, Jennifer M. McGoogan, Zun-You Wu
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001447
摘要
Background:
Despite almost two decades of well-funded and comprehensive response efforts by the Chinese Government, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) remains a major problem in China. Yet, few studies have recently examined long-term trends in HIV/AIDS prevalence, incidence, and mortality at the national level. This study aimed to determine the prevalence, incidence, and mortality trends for HIV/AIDS over the past 28 years in China.
Methods:
We conducted a descriptive, epidemiological, secondary analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 data. To evaluate trends in prevalence, incidence, and mortality over the study period from 1990 to 2017, we calculated values for annual percentage change (APC) and corresponding 95% confidence intervals (CIs) using joinpoint regression analysis.
Results:
A significant increase in HIV/AIDS prevalence was observed for 1990 to 2009 (APC: 10.7; 95% CI: 10.4, 11.0; P < 0.001), and then remained stable for 2009 to 2017 (APC: 0.7; 95% CI: -0.3, 1.7; P = 0.1). A significant increase in HIV incidence was also observed for 1990 to 2005 (APC: 13.0; 95% CI: 12.6, 13.4; P < 0.001), and then a significant decrease was detected for 2005 to 2017 (APC: -6.5; 95% CI: -7.0, -6.1; P < 0.001). A significant increase in AIDS-related mortality rate was detected for 1990 to 2004 (APC: 10.3; 95% CI: 9.3, 11.3; P < 0.001), followed by a period of stability for 2004 to 2013 (APC: 1.3; 95% CI: -0.7, 3.3; P = 0.2), and then another significant increase for 2013 to 2017 (APC: 15.3; 95% CI: 8.7, 22.2; P < 0.001).
Conclusions:
Although prevalence has stabilized and incidence has declined, AIDS-related mortality has risen sharply in recent years. These findings suggest more must be done to bring people into treatment earlier, retain them in treatment more effectively, actively seek to reenter them in treatment if they dropout, and improve the quality of treatment and care regimens.
开放获取
三期CT灌注参数及直方图分析在肝细胞癌组织学分级术前预测中的价值Chun-Chun Shao, Fang Zhao, Yi-Fan Yu, Lin-Lin Zhu, Guo-Dong Pang
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001446
摘要
Background:
Pre-operative non-invasive histological evaluation of hepatocellular carcinoma (HCC) remains a challenge. Tumor perfusion is significantly associated with the development and aggressiveness of HCC. The purpose of the study was to evaluate the clinical value of quantitative liver perfusion parameters and corresponding histogram parameters derived from traditional triphasic enhanced computed tomography (CT) scans in predicting histological grade of HCC.
Methods:
Totally, 52 patients with HCC were enrolled in this retrospective study and underwent triple-phase enhanced CT imaging. The blood perfusion parameters were derived from triple-phase CT scans. The relationship of liver perfusion parameters and corresponding histogram parameters with the histological grade of HCC was analyzed. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal ability of the parameters to predict the tumor histological grade.
Results:
The variance of arterial enhancement fraction (AEF) was significantly higher in HCCs without poorly differentiated components (NP-HCCs) than in HCCs with poorly differentiated components (P-HCCs). The difference in hepatic blood flow (HF) between total tumor and total liver flow (ΔHF = HFtumor -HFliver) and relative flow (rHF = ΔHF/HFliver) were significantly higher in NP-HCCs than in P-HCCs. The difference in portal vein blood supply perfusion (PVP) between tumor and liver tissue (ΔPVP) and the ΔPVP/liver PVP ratio (rPVP) were significantly higher in patients with NP-HCCs than in patients with P-HCCs. The area under ROC (AUC) of ΔPVP and rPVP were both 0.697 with a high sensitivity of 84.2% and specificity of only 56.2%. The ΔHF and rHF had a higher specificity of 87.5% with an AUC of 0.681 and 0.673, respectively. The combination of rHF and rPVP showed the highest AUC of 0.732 with a sensitivity of 57.9% and specificity of 93.8%. The combined parameter of ΔHF and rPVP, rHF and rPVP had the highest positive predictive value of 0.903, and that of rPVP and ΔPVP had the highest negative predictive value of 0.781.
Conclusion:
Liver perfusion parameters and corresponding histogram parameters (including ΔHF, rHF, ΔPVP, rPVP, and AEFvariance) in patients with HCC derived from traditional triphasic CT scans may be helpful to non-invasively and pre-operatively predict the degree of the differentiation of HCC.
开放获取
大庆糖尿病研究中的皮肤病：一项横断面研究Chang-Bing Shen, Xin Qian, Rui-Xing Yu, Xue-Lei Ji, Yin-Juan Shi, Jing Gao, Cheng-Xu Li, Ke-Ke Li, Wen-Min Fei, Xue Shen 等
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001453
摘要
Background:
The prevalence of skin diseases and diabetes mellitus (DM) are prominent around the world. The current scope of knowledge regarding the prevalence of skin diseases and comorbidities with type 2 DM (T2DM) is limited, leading to limited recognition of the correlations between skin diseases and T2DM.
Methods:
We collected 383 subjects from the Da Qing Diabetes Study during the period from July 9th to September 1st, 2016. The subjects were categorized into three groups: Normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and T2DM. The prevalence and clinical characteristics of skin diseases were recorded and investigated.
Results:
In this cross-sectional study, 383 individuals with ages ranging from 53 to 89-year-old were recruited. The overall prevalence of skin diseases was 93.5%, and 75.7% of individuals had two or more kinds of skin diseases. Additionally, there were 47 kinds of comorbid skin diseases in patients with T2DM, of which eight kinds of skin diseases had a prevalence >10%. The prevalence of skin diseases in NGT, IGT, and T2DM groups were 93.3%, 91.5%, and 96.6%, respectively; stratified analysis by categories showed a statistically significant difference in "disturbances of pigmentation" and "neurological and psychogenic dermatoses" . The duration of T2DM also significantly associated with the prevalence of "disturbances of pigmentation" and "neurological and psychogenic dermatoses" . Subsequently, the prevalence of "disturbances of pigmentation" was higher in males than females in NGT (P < 0.01) and T2DM (P < 0.01) groups. In addition, the difference in the prevalence of "disturbances of pigmentation" was also significant in NGT and T2DM groups (P < 0.01).
Conclusions:
There was a high prevalence of skin diseases in the Da Qing Diabetes Study. To address the skin diseases in the Da Qing Diabetes Study, increased awareness and intervention measures should be implemented.
开放获取
B细胞急性淋巴细胞白血病患者异基因干细胞移植后复发风险分层的风险评分系统Le-Qing Cao, Yang Zhou, Yan-Rong Liu, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han 等
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001402
摘要
Background:
For patients with B cell acute lymphocytic leukemia (B-ALL) who underwent allogeneic stem cell transplantation (allo-SCT), many variables have been demonstrated to be associated with leukemia relapse. In this study, we attempted to establish a risk score system to predict transplant outcomes more precisely in patients with B-ALL after allo-SCT.
Methods:
A total of 477 patients with B-ALL who underwent allo-SCT at Peking University People’s Hospital from December 2010 to December 2015 were enrolled in this retrospective study. We aimed to evaluate the factors associated with transplant outcomes after allo-SCT, and establish a risk score to identify patients with different probabilities of relapse. The univariate and multivariate analyses were performed with the Cox proportional hazards model with time-dependent variables.
Results:
All patients achieved neutrophil engraftment, and 95.4% of patients achieved platelet engraftment. The 5-year cumulative incidence of relapse (CIR), overall survival (OS), leukemia-free survival (LFS), and non-relapse mortality were 20.7%, 70.4%, 65.6%, and 13.9%, respectively. Multivariate analysis showed that patients with positive post-transplantation minimal residual disease (MRD), transplanted beyond the first complete remission (≥CR2), and without chronic graft-versus-host disease (cGVHD) had higher CIR (P < 0.001, P= 0.004, and P < 0.001, respectively) and worse LFS (P < 0.001, P= 0.017, and P < 0.001, respectively), and OS (P < 0.001, P = 0.009, and P < 0.001, respectively) than patients without MRD after transplantation, transplanted in CR1, and with cGVHD. A risk score for predicting relapse was formulated with the three above variables. The 5-year relapse rates were 6.3%, 16.6%, 55.9%, and 81.8% for patients with scores of 0, 1, 2, and 3 (P < 0.001), respectively, while the 5-year LFS and OS values decreased with increasing risk score.
Conclusion:
This new risk score system might stratify patients with different risks of relapse, which could guide treatment.
开放获取
微型经皮肾镜取石术与后腹腔镜输尿管取石术治疗15mm以上嵌顿性输尿管近端结石的比较Guo-Liang Lu, Xiao-Jin Wang, Bao-Xing Huang, Yang Zhao, Wei-Chao Tu, Xing-Wei Jin, Yuan Shao, Da-Wei Wang
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001417
摘要
Background:
The optimal treatment for large impacted proximal ureteral stones remains controversial. The aim of this study was to evaluate the efficacy, safety, and potential complications of mini-percutaneous nephrolithotomy (MPCNL) and retroperitoneal laparoscopic ureterolithotomy (RPLU) in the treatment of impacted proximal ureteral stones with size greater than 15 mm.
Methods:
A total of 268 patients with impacted proximal ureteral stones greater than 15 mm who received MPCNL or RPLU procedures were enrolled consecutively between January 2014 and January 2019. Data on surgical outcomes and complications were collected and analyzed.
Results:
Demographic and ureteral stone characteristics found between these two groups were not significantly different. The surgical success rate (139/142, 97.9% vs. 121/126, 96.0%, P = 0.595) and stone-free rate after 1 month (139/142, 97.9% vs. 119/126, 94.4%, P = 0.245) of RPLU group were marginally higher than that of the MPCNL group, but there was no significant difference. There was no significant difference in the drop of hemoglobin between the two groups (0.8 ± 0.6 vs. 0.4 ± 0. 2 g/dL, P = 0.621). The mean operative time (68.2 ± 12.5 vs. 87.2 ± 16.8 min, P = 0.041), post-operative analgesics usage (2/121, 1.7% vs. 13/139, 9.4%, P = 0.017), length of hospital stay after surgery (2.2 ± 0.6 vs. 4.8 ± 0.9 days, P < 0.001), double J stent time (3.2 ± 0.5 vs. 3.9 ± 0.8 days, P = 0.027), time of catheterization (1.1 ± 0.3 vs. 3.5 ± 0.5 days, P < 0.001), and time of drainage tube (2.3 ± 0.3 vs. 4.6 ± 0.6 days, P < 0.001) of MPCNL group were significantly shorter than that of the RPLU group. The complication rate was similar between the two groups (20/121, 16.5% vs. 31/139, 22.3%, P = 0.242).
Conclusions:
MPCNL and RPLU have similar surgical success and stone clearance in treating impacted proximal ureteral stones greater than 15 mm, while patients undergoing MPCNL had a lower post-operative pain rate and a faster recovery.
Clinical Observation
开放获取
慢性完全闭塞经皮冠状动脉介入治疗低帧率方案的安全性和有效性Ming-Huan Fu, Yuan-Yuan Pan, Xue-Fei Tao, Juan Du, Biao Cheng
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001395
摘要
慢性完全闭塞（CTO）是冠状动脉完全闭塞>3个月，合并心肌梗死（TIMI）流量0级溶栓。经皮冠状动脉介入治疗（PCI）广泛用于治疗CTO，但使用少于冠状动脉旁路移植术（CABG）。[
开放获取
孕妇和非孕妇冠状病毒疾病2019：一项回顾性研究Ying Zha, Ge Chen, Xun Gong, Yuan-Yuan Wu, Xing-Guang Lin, Jian-Li Wu, Ya-Fei Huang, Yu-Qi Li, Ying Zhang, Dong-Rui Deng 等
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001396
摘要
冠状病毒疾病2019（新冠肺炎）源于感染新型严重急性呼吸综合征冠状病毒2（新型冠状病毒）。[
Technical Notes
开放获取
一种新的神经节脉冲射频消融技术Ji Yeong Kim, Sung Eun Sim, Subin Yoo, Mina Joo, Hue Jung Park
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001423
摘要
神经节阻滞最早由Plancarte于1990年提出等人.[
Rapid Report
开放获取
两种新的谱蛋白的克隆、表达和免疫学特征黄花蒿Qiao-Li Hu, Li-Xiang Zhu, Zhi-Qiang Xu, Chen Pan, Qiu-Min Zhong, Jin-Lyu Sun, Ji-Fu Wei
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001309
摘要
近几十年来，在发达国家和发展中国家，过敏性疾病的发病率都在迅速增加。[
Correspondence
开放获取
A case report of successful treatment of severe traumatic brain injury by prolonged targeted temperature managementNan-Jun Zhou, Zhan-Hong Tang
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001282
开放获取
Prolonged and recurrent hypoglycemia induced by trimethoprim-sulfamethoxazole in a Hodgkin lymphoma patient with Pneumocystis carinii pneumoniaBing-Jie Wang, Zhi-Hao Liu, Qing-Yun Wang, Wei Liu, Bo Tang, Zhi-Xiang Qiu, Wen-Sheng Wang, Mang-Ju Wang, Jin-Ping Ou, Han-Yun Ren 等
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001285
开放获取
胃肠道三重同步原发肿瘤Fozan Mohammed Sauri, Eman Adnan Zakarneh, Mohammed Yousef Alessa, Ahmad Hammad Sakr, Yeon Seung Chung, Ho Seung Kim, Nam kyu Kim
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001389
摘要
致编辑：大多数多原发恶性肿瘤是异时性的或涉及一个以上系统，相反，我们描述了一个涉及一个器官系统的同步三重癌症的病例。
开放获取
上皮性卵巢癌肝转移的治疗Hao Deng, Hong-Lan Zhu, Yi Li, Yue Wang, Yan Wu, Heng Cui, Jian-Liu Wang, Xiao-Ping Li
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001332
摘要
致编辑：肝脏是转移性肿瘤最脆弱的器官之一。肝转移性肿瘤比原发性肝肿瘤(LM)常见约18至40倍。中国每年新发卵巢癌患者约5万人，年死亡率约40%。[
开放获取
中国大学生痤疮患病率及其与社会决定因素和生活质量的关系：一项基于人群的横断面研究Li Zhu, Min-Xue Shen, Elham Samran, Ya-Ting Tu, Xiang Chen, Juan Tao, Yan Li
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001292
摘要
致编辑：寻常痤疮是一种常见的慢性炎症性皮肤病。它是世界上第八大流行疾病。在青少年中，超过85%的人曾经患有痤疮。[
开放获取
慢性主观性耳鸣急性加重的横断面研究Bi-Xing Fang, Yin-Fei Liang, Jing Gu, Zhi-Cheng Li, Zhen-Zhi Li, Jin-Tian Cen, Lian-Xiong Yuan, Ke Zheng, Dan Chen, Xiang-Li Zeng
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001382
摘要
致编辑：耳鸣是在没有外界声音的情况下对声音的印象。耳鸣影响10%至15%的成年人，大约20%的耳鸣患者认为这很烦人。[
开放获取
海姆泊芬光动力治疗单侧痣样毛细血管扩张1例Jie Kang, Han-Jin Xie, Yan-Yan Lin, Li-Hang Lin, Xue-Min Xiao
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001335
摘要
致编辑：单侧痣样毛细血管扩张症（UNT）是一种罕见的皮肤血管疾病，其特征是以单侧线性模式分布的浅表毛细血管扩张。它可以是先天性的，也可以是后天性的。UNT的发病机制尚不清楚，大多数学者认为高雌激素状态在UNT中起重要作用。脉冲染料激光（PDL）疗法是一种主流治疗选择。在此，我们提出了一个用海姆泊芬介导的光动力疗法（HMME-PDT）成功治疗PDL耐药UNT的病例。
开放获取
上海地区单纯性肝囊肿患病率及相关因素：一项基于人群的横断面研究Wen-Ping Xu, Xiao-Hang Wang, Shao-Ping Wu, Pei-Mei Shi, Zong-Li Yuan, Yi-Bin Guo, Xin Zeng, Wei-Fen Xie
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001361
摘要
致编辑：单纯性肝囊肿是胃肠病科和肝病科就诊的常见原因。虽然大多数患者病程为良性，但也有部分患者出现严重并发症，如囊内感染、出血，甚至破裂，或周围组织器官受到严重压迫而引起的症状。了解单纯性肝囊肿的患病率、特点及相关因素有助于更好地治疗有症状的患者。报告的该病患病率差异很大，从2.5%到18.0%不等，大多数是基于医院调查。[
开放获取
真性红细胞增多症患者的脑静脉窦血栓形成杰克2V617F突变Hui-Xin Shen, Xiao-Qin Huang, Chun-Qiu Fan, Yan-Xiang Cao, Hong Zhao, Jian-Gang Duan
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001484
摘要
致编辑：真性红细胞增多症[
开放获取
压电型机械敏感离子通道成分2复合杂合突变的罕见病例（压电2）诱发气管支气管软化症Juan Wu, Lin Zhong, Ting Chen, Li Qiu, Yi-Fei Li
中华医学杂志英文版2021年 134卷 10期
DOI: 10.1097/CM9.0000000000001500
摘要
致编辑：气管支气管软化症(TBM)是一种由软骨畸形引起的疾病；该畸形由于原发性或继发性原因导致气管或支气管畸形，呼气时横截面缩小≥50%。[
本期目次
下载本期封面 下载本期目录
